COFCO Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 14,721.19 million compared to CNY 14,896.32 million a year ago. Revenue was CNY 14,721.19 million compared to CNY 14,896.32 million a year ago.

Net loss was CNY 332.87 million compared to net income of CNY 965.65 million a year ago. Basic loss per share from continuing operations was CNY 0.1818 compared to basic earnings per share from continuing operations of CNY 0.5196 a year ago.